Ken Bartizal Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ken Bartizal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ken Bartizal. Ken Bartizal is a Chief Development Officer in Trius Therapeutics Inc ($TSRX) and a Chief Development Officer in Cidara Therapeutics, Inc. ($CDTX).
Address: C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO 92121 CA
Companies in which Ken Bartizal is an Insider
Cidara Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ken Bartizal: Chief Development Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 18 2016
$CDTX Market Capitalization: $167.56M
$CDTX Previous Close: $9.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trius Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ken Bartizal: Chief Development Officer
Holdings: 109,844 shares
Latest Transaction: Mar 11 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ken Bartizal
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2016 | CDTX | Cidara Therapeutic ... | Bartizal Ken | Chief Development O ... | Option Exercise | A | 9.89 | 50,000 | 494,500 | 50,000 | |
| Mar 11 2013 | TSRX | Trius Therapeutics ... | Bartizal Ken | Chief Development O ... | Option Exercise | A | 6.13 | 90,000 | 551,700 | 90,000 | |
| Nov 18 2011 | TSRX | Trius Therapeutics ... | Bartizal Ken | Chief Development O ... | Sell | S | 7.85 | 1,687 | 13,243 | 109,844 | 111.5 K to 109.8 K (-1.51 %) |
| Nov 05 2010 | TSRX | Trius Therapeutics ... | Bartizal Ken | Chief Development O ... | Option Exercise | A | 3.50 | 10,000 | 35,000 | 10,000 | |
| Nov 05 2010 | TSRX | Trius Therapeutics ... | Bartizal Ken | Chief Development O ... | Option Exercise | A | 3.50 | 30,000 | 105,000 | 30,000 |